These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8970603)
1. Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig. Yin DP; Sankary HN; Williams J; Krieger N; Fathman CG Transplantation; 1996 Dec; 62(11):1537-9. PubMed ID: 8970603 [TBL] [Abstract][Full Text] [Related]
2. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. Yin DP; Sankary HN; Talor-Edwards C; Chong AS; Foster P; Shen J; Ma LL; Williams JW; Fathman CG Transplantation; 1998 Jul; 66(1):1-5. PubMed ID: 9679814 [TBL] [Abstract][Full Text] [Related]
3. Induction of tolerance to heart allografts in high responder rats by combining anti-CD4 with CTLA4Ig. Yin D; Fathman CG J Immunol; 1995 Aug; 155(4):1655-9. PubMed ID: 7636225 [TBL] [Abstract][Full Text] [Related]
4. Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats. Yin DP; Sankary HN; Chong AS; Blinder L; Ma LL; Williams JW Transplantation; 1997 Jul; 64(2):317-21. PubMed ID: 9256194 [TBL] [Abstract][Full Text] [Related]
5. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2. Onodera K; Chandraker A; Volk HD; Ritter T; Lehmann M; Kato H; Sayegh MH; Kupiec-Weglinski JW Transplantation; 1999 Jul; 68(2):288-93. PubMed ID: 10440403 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of immunosuppression in composite tissue allografts by systemic administration of CTLA4Ig. Iwasaki N; Gohda T; Yoshioka C; Murakami M; Inobe M; Minami A; Uede T Transplantation; 2002 Feb; 73(3):334-40. PubMed ID: 11884927 [TBL] [Abstract][Full Text] [Related]
7. CTLA4IgG treatment induces long-term acceptance of rat small bowel allografts. Tarumi K; Murakami M; Yagihashi A; Nakagawa I; Hirata K; Uede T Transplantation; 1999 Feb; 67(4):520-5. PubMed ID: 10071020 [TBL] [Abstract][Full Text] [Related]
8. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion. Rehman A; Tu Y; Arima T; Linsley PS; Flye MW Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584 [TBL] [Abstract][Full Text] [Related]
9. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig. Yang Z; Rostami S; Koeberlein B; Barker CF; Naji A Transplantation; 1999 Jun; 67(12):1517-23. PubMed ID: 10401757 [TBL] [Abstract][Full Text] [Related]
10. Protection of corneal allografts by CTLA4-Ig. Gebhardt BM; Hodkin M; Varnell ED; Kaufman HE Cornea; 1999 May; 18(3):314-20. PubMed ID: 10336035 [TBL] [Abstract][Full Text] [Related]
11. Prevention of acute lung allograft rejection in rat by CTLA4Ig. Shiraishi T; Yasunami Y; Takehara M; Uede T; Kawahara K; Shirakusa T Am J Transplant; 2002 Mar; 2(3):223-8. PubMed ID: 12096784 [TBL] [Abstract][Full Text] [Related]
12. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. Lin H; Bolling SF; Linsley PS; Wei RQ; Gordon D; Thompson CB; Turka LA J Exp Med; 1993 Nov; 178(5):1801-6. PubMed ID: 8228826 [TBL] [Abstract][Full Text] [Related]
13. CTLA-4IG treatment induces long-term acceptance of rat small bowel allografts. Tarumi K; Yagihashi A; Tsuruma T; Araya J; Hirata K Transplant Proc; 2000 Nov; 32(7):2028-31. PubMed ID: 11120051 [No Abstract] [Full Text] [Related]
14. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887 [TBL] [Abstract][Full Text] [Related]
15. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. Sayegh MH; Akalin E; Hancock WW; Russell ME; Carpenter CB; Linsley PS; Turka LA J Exp Med; 1995 May; 181(5):1869-74. PubMed ID: 7536798 [TBL] [Abstract][Full Text] [Related]